New York Presbyterian Hospital, Weill Cornell Medical College, Greenberg Division of Cardiology, New York, New York, USA.
J Am Coll Cardiol. 2013 Apr 23;61(16):1688-95. doi: 10.1016/j.jacc.2012.11.073. Epub 2013 Mar 27.
The goal of this study was to characterize nonsystem reasons for delay in door-to-balloon time (D2BT) and the impact on in-hospital mortality.
Studies have evaluated predictors of delay in D2BT, highlighting system-related issues and patient demographic characteristics. Limited data exist, however, for nonsystem reasons for delay in D2BT.
We analyzed nonsystem reasons for delay in D2BT among 82,678 ST-segment elevation myocardial infarction patients who underwent primary percutaneous coronary intervention within 24 h of symptom onset in the CathPCI Registry from January 1, 2009, to June 30, 2011.
Nonsystem delays occurred in 14.7% of patients (n = 12,146). Patients with nonsystem delays were more likely to be older, female, African American, and have greater comorbidities. The in-hospital mortality for patients treated without delay was 2.5% versus 15.1% for those with delay (p < 0.01). Nonsystem delay reasons included delays in providing consent (4.4%), difficult vascular access (8.4%), difficulty crossing the lesion (18.8%), "other" (31%), and cardiac arrest/intubation (37.4%). Cardiac arrest/intubation delays had the highest in-hospital mortality (29.9%) despite the shortest time delay (median D2BT: 84 min; 25th to 75th percentile: 64 to 108 min); delays in providing consent had a relatively lower in-hospital mortality rate (9.4%) despite the longest time delay (median D2BT: 100 min; 25th to 75th percentile: 80 to 131 min). Mortality for delays due to difficult vascular access, difficulty crossing a lesion, and other was also higher (8.0%, 5.6%, and 5.9%, respectively) compared with nondelayed patients (p < 0.0001). After adjustment for baseline characteristics, in-hospital mortality remained higher for patients with nonsystem delays.
Nonsystem reasons for delay in D2BT in ST-segment elevation myocardial infarction patients presenting for primary percutaneous coronary intervention are common and associated with high in-hospital mortality.
本研究旨在描述门球时间(D2BT)延迟的非系统原因及其对住院死亡率的影响。
已有研究评估了 D2BT 延迟的预测因素,强调了与系统相关的问题和患者人口统计学特征。然而,关于 D2BT 延迟的非系统原因的数据有限。
我们分析了 2009 年 1 月 1 日至 2011 年 6 月 30 日 CathPCI 注册中心登记的 82678 例 ST 段抬高型心肌梗死患者中,在症状发作 24 小时内行直接经皮冠状动脉介入治疗患者的 D2BT 非系统延迟原因。
14.7%(n=12146)的患者发生非系统延迟。与无延迟的患者相比,有延迟的患者年龄更大、女性、非裔美国人、合并症更多。无延迟患者的住院死亡率为 2.5%,而有延迟患者的住院死亡率为 15.1%(p<0.01)。非系统延迟的原因包括同意书签署延迟(4.4%)、血管入路困难(8.4%)、病变跨越困难(18.8%)、“其他”(31%)和心脏骤停/插管(37.4%)。尽管心脏骤停/插管延迟的 D2BT 最短(中位数:84 分钟;25 至 75 百分位数:64 至 108 分钟),但其住院死亡率最高(29.9%);尽管同意书签署延迟的 D2BT 最长(中位数:100 分钟;25 至 75 百分位数:80 至 131 分钟),但其住院死亡率相对较低(9.4%)。血管入路困难、病变跨越困难和其他原因所致的延迟死亡率也高于非延迟患者(分别为 8.0%、5.6%和 5.9%,p<0.0001)。在调整基线特征后,非系统 D2BT 延迟患者的住院死亡率仍较高。
ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时,D2BT 延迟的非系统原因常见,且与较高的住院死亡率相关。